2gpl
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2gpl.gif|left|200px]] | [[Image:2gpl.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2gpl", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2gpl| PDB=2gpl | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors''' | '''TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors''' | ||
Line 31: | Line 28: | ||
[[Category: Moroder, M.]] | [[Category: Moroder, M.]] | ||
[[Category: Weyher, E.]] | [[Category: Weyher, E.]] | ||
- | [[Category: | + | [[Category: Ntn-hydrolase]] |
- | [[Category: | + | [[Category: Proteasomal subunit fold represents an antiparallel beta-sheet flanked by helice]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 05:22:24 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 02:22, 4 May 2008
TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors
Overview
TMC-95's natural cyclic tripeptide metabolites represent potent competitive proteasome inhibitors. The constrained conformation of TMC-95 proteasomal inhibitors provides the driving force for entropically high-affinity binding. Based on the crystal structure of the proteasome:TMC-95A complex, the synthetically challenging TMC-95 core structure was used for the design and synthesis of less demanding biphenyl-ether macrocycles, in which the biphenyl-ether moiety functions as an endocyclic clamp restricting its tripeptide backbone. These simplified analogs allowed us to identify high plasticity of the proteasomal tryptic-like specificity pocket. Biphenyl-ether compounds extended with an amide group were hydrolyzed by the proteasome, although the crystal structure of such proteasome:biphenyl-ether complexes revealed quenching of proteolysis at the acyl-enzyme intermediate. Our data reveal that biphenyl-ether derivatives bind noncovalently to the proteasomal tryptic-like active site in a reversible substrate-like manner without allosteric changes of active site residues.
About this Structure
2GPL is a Protein complex structure of sequences from Saccharomyces cerevisiae. Full crystallographic information is available from OCA.
Reference
TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome., Groll M, Gotz M, Kaiser M, Weyher E, Moroder L, Chem Biol. 2006 Jun;13(6):607-14. PMID:16793518 Page seeded by OCA on Sun May 4 05:22:24 2008